bioRxivPhysiologyPreprint
Short term effect of tetrahydrocurcumin on adipose angiogenesis in very high-fat diet-induced obesity mouse model
B. Yoysungnoen, U. Srisawat, P. Piyabhan, N. Sookprasert, N. Duansak, N. Mathuradavong, N. Poomipark, N. Munkong, C. Changtam
Abstract
Tetrahydrocurcumin (THC) has been shown to possess anti-angiogenic activities. This study aims to investigate the effects of THC on adipose angiogenesis and expression of angiogenic factors that occurs in 60% high-fat diet-induced obese mice. Male ICR mice were randomly divided into 3 groups: mice fed with a low-fat diet (LFD group); mice fed with very high fat diet (VHFD group), and mice fed with VHFD supplemented with THC (300 mg/kg/day orally)(VHFD+THC group) for 6 weeks. Body weight (BW), food intake, fasting blood sugar (FBS), lipid profiles and visceral fats weight (VF) were measured. The microvascular density (MVD), VEGF, MMP-2 and MMP-9 expressions were evaluated. The VHFD group had significantly increased total cholesterol, triglyceride, food intake, BW, VF, VF/BW ratio, adipocyte size and the number of crown-liked structures as compared to LFD group. THC supplementation markedly reduced these parameters and adipocyte hypertrophy and inflammation in white adipose tissues. MVD, VEGF, MMP-2 and MMP-9 were over-expressed in the VHFD group. However, THC supplementation decreased MVD and reduced expression of VEGF, MMP-2 and MMP-9. In conclusion, THC suppressed angiogenesis in adipose tissue by the downregulation of VEGF, MMP-2 and MMP-9. With its effects on lipid metabolism as well as on food consumption, THC could contribute to lower visceral fat and body weight. Overall, our study demonstrated the potential benefit of THC in mitigating obesity and associated metabolic disorders along with elucidated the suppression of adipose angiogenesis as one of its underlying mechanisms. Author summaryConceptualization, B.Y, U.S., P.P., N.D., N.S. and N.M3.; methodology, B.Y., U.S., P.P., N.D., N.S., N.M3., and C.C; validation, B.Y., U.S., P.P., N.D., N.S., N.M1., and N.M3.; formal analysis, B.Y., U.S, N.S., N.M1., N.P., and N.M3; investigation, B.Y., U.S, N.S., N.M1., N.P., and N.M3.; resources, B.Y. and C.C.; data curation, B.Y. and N.M1.; writing--original draft preparation, BY; writing--review and editing, B.Y; visualization, B.Y., U.S., P.P., and N.D.; supervision, B.Y.; project administration, B.Y., U.S., P.P., N.S., and N.P.; funding acquisition, B.Y., U.S., P.P., N.S., and N.P.
- organism: mouse
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Tetrahydrocannabinolic Acid A (THCA-A) Reduces Adiposity And Prevents Metabolic Disease Caused By Diet-Induced Obesity
B. Palomares, F. Ruiz-Pino, … E. Munoz·bioRxiv·Apr 29, 2019
- A very-low carbohydrate content in a high-fat diet modifies the plasma metabolome and alleviates experimental atherosclerosis
R. Castro, K. Kalecky, … T. Bottiglieri·bioRxiv·Feb 7, 2023
- Transient Overexpression of VEGF-A in Adipose Tissue Promotes Energy Expenditure via Activation of the Sympathetic Nervous System
- Mast cell-driven adipocyte lipolysis promotes post-expansive VAT atrophy and ectopic hepatic steatosis
Jiahui Wang, Lei Zhang, … Jian Liu·bioRxiv·Jan 8, 2026
- Metabolomics identifies endocannabinoid system remodeling during obesity associated inflammation in adipose tissue
Nasim Bararpour, Tiziana Caputo, … Aurélien Thomas·bioRxiv·Sep 28, 2026
- HIF1α controls adipose tissue growth through metabolic rechanneling
Chaonan Zhu, Meiqian Wu, … Jaya Krishnan·bioRxiv·May 28, 2024